GRACE-trial: vulvovaginal atrophy in BC patients on endocrine therapy
Dr Glen Vergauwen from Ghent University Hospital introduces the GRACE trial, a randomized controlled clinical trial targeting breast cancer patients experiencing vaginal atrophy during endocrine therapy. The study aims to compare four distinct treatment strategies, addressing a current gap in the existing literature. Patient enrollment is currently underway, with anticipated results expected within a timeframe of two to three years.
Reference:
Vergauwen G, GRACE-trial, a randomized active-controlled trial for vulvovaginal atrophy in breast cancer patients on endocrine therapy: study protocol.. SABCS 2023, #PO4-17-12
You may also be interested in:
With the educational support of:
 |
 |
 |